Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17.
TNF
inflammation
proteases
tetraspanin
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
29 08 2022
29 08 2022
Historique:
received:
20
07
2022
accepted:
09
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Ectodomain shedding is an irreversible process to regulate inter- and intracellular signaling. Members of the a disintegrin and metalloprotease (ADAM) family are major mediators of ectodomain shedding. ADAM17 is involved in the processing of multiple substrates including tumor necrosis factor (TNF) α and EGF receptor ligands. Substrates of ADAM17 are selectively processed depending on stimulus and cellular context. However, it still remains largely elusive how substrate selectivity of ADAM17 is regulated. Tetraspanins (Tspan) are multi-membrane-passing proteins that are involved in the organization of plasma membrane micro-domains and diverse biological processes. Closely related members of the Tspan8 subfamily, including CD9, CD81 and Tspan8, are associated with cancer and metastasis. Here, we show that Tspan8 subfamily members use different strategies to regulate ADAM17 substrate selectivity. We demonstrate that in particular Tspan8 associates with both ADAM17 and TNF α and promotes ADAM17-mediated TNF α release through recruitment of ADAM17 into Tspan-enriched micro-domains. Yet, processing of other ADAM17 substrates is not altered by Tspan8. We, therefore, propose that Tspan8 contributes to tumorigenesis through enhanced ADAM17-mediated TNF α release and a resulting increase in tissue inflammation.
Identifiants
pubmed: 36078095
pii: cells11172683
doi: 10.3390/cells11172683
pmc: PMC9454446
pii:
doi:
Substances chimiques
Disintegrins
0
Membrane Proteins
0
Tetraspanins
0
Tumor Necrosis Factor-alpha
0
ADAM Proteins
EC 3.4.24.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Biol Chem. 2016 Sep 1;397(9):857-69
pubmed: 27180358
Science. 2012 Jan 13;335(6065):225-8
pubmed: 22246777
Cell Mol Life Sci. 2012 Sep;69(17):2919-32
pubmed: 22446748
Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):217-230
pubmed: 27818272
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2059-2070
pubmed: 28705384
Oncotarget. 2015 Feb 10;6(4):2366-84
pubmed: 25544774
Biochem J. 2006 Dec 1;400(2):315-25
pubmed: 16859490
Inflamm Bowel Dis. 2013 Jun;19(7):1365-73
pubmed: 23702712
Nat Rev Cancer. 2008 Dec;8(12):929-41
pubmed: 19005493
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11433-8
pubmed: 23801765
Mol Aspects Med. 2008 Oct;29(5):258-89
pubmed: 18762209
Cell Mol Life Sci. 2011 Oct;68(19):3275-92
pubmed: 21365281
Nat Commun. 2016 May 10;7:11523
pubmed: 27161080
FASEB J. 2009 Nov;23(11):3674-81
pubmed: 19587294
Semin Cell Dev Biol. 2009 Apr;20(2):126-37
pubmed: 19049889
Nature. 1997 Feb 20;385(6618):729-33
pubmed: 9034190
Methods Mol Biol. 2014;1137:1-15
pubmed: 24573470
Exp Mol Med. 2014 Apr 04;46:e89
pubmed: 24699135
Nat Biotechnol. 2005 Mar;23(3):355-60
pubmed: 15696158
Nature. 1997 Feb 20;385(6618):733-6
pubmed: 9034191
J Cell Biol. 2012 Oct 29;199(3):481-96
pubmed: 23091066
J Hepatol. 2016 Jun;64(6):1403-15
pubmed: 26867490
Oncogene. 2016 Aug 25;35(34):4540-8
pubmed: 26804173
Int J Biol Sci. 2019 Jan 1;15(2):493-506
pubmed: 30745837
Cell Mol Life Sci. 2011 Oct;68(20):3323-35
pubmed: 21687991
Br J Cancer. 2011 Jan 4;104(1):155-65
pubmed: 21081927
Mediators Inflamm. 2017;2017:9673537
pubmed: 29230082
J Biol Chem. 2020 Mar 27;295(13):4350-4358
pubmed: 32060096
J Biol Chem. 2003 Oct 3;278(40):38829-39
pubmed: 12832423
J Immunol. 2008 Nov 15;181(10):7002-13
pubmed: 18981120
Cell Death Dis. 2014 Jul 17;5:e1326
pubmed: 25032849
Front Immunol. 2018 Nov 05;9:2474
pubmed: 30455686
J Cell Mol Med. 2012 Mar;16(3):627-36
pubmed: 21645239
PLoS One. 2014 Sep 15;9(9):e107247
pubmed: 25221999
Hepatology. 2017 Jan;65(1):89-103
pubmed: 27770462
J Cell Sci. 2014 Sep 1;127(Pt 17):3641-8
pubmed: 25128561
Nat Methods. 2011 Nov 29;8(12):990-2
pubmed: 22127214
Chem Biol. 2012 Mar 23;19(3):353-60
pubmed: 22444590
Eur J Immunol. 2003 Sep;33(9):2479-89
pubmed: 12938224
Science. 2012 Jan 13;335(6065):229-32
pubmed: 22246778
Science. 1998 Nov 13;282(5392):1281-4
pubmed: 9812885
Semin Immunopathol. 2017 Jun;39(4):365-383
pubmed: 28213794
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Mol Cancer Res. 2007 Jun;5(6):553-67
pubmed: 17579117
Cell. 2013 Oct 10;155(2):384-96
pubmed: 24120137
J Cell Biol. 2008 Aug 25;182(4):765-76
pubmed: 18710926
Trends Cell Biol. 2009 Sep;19(9):434-46
pubmed: 19709882
Nat Clin Pract Rheumatol. 2008 Jun;4(6):300-9
pubmed: 18414459
Mol Immunol. 2015 Jun;65(2):416-28
pubmed: 25745808
J Cell Biol. 2001 Dec 24;155(7):1103-7
pubmed: 11756464
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Platelets. 2017 Jun;28(4):333-341
pubmed: 27256961
J Biol Chem. 2012 Nov 16;287(47):39753-65
pubmed: 23035126
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Mol Biol Cell. 2000 May;11(5):1645-55
pubmed: 10793141
FASEB J. 2020 Apr;34(4):4956-4969
pubmed: 32103528
Oncogene. 2019 May;38(20):3781-3793
pubmed: 30679790
Cell Mol Life Sci. 2018 Sep;75(17):3251-3267
pubmed: 29520422
Nat Methods. 2012 Oct;9(10):1021-9
pubmed: 22983457
Nat Rev Cancer. 2009 May;9(5):361-71
pubmed: 19343034
J Exp Med. 2018 Apr 2;215(4):1205-1225
pubmed: 29472497
Nat Rev Cancer. 2014 Jan;14(1):49-60
pubmed: 24505619
Cell. 2016 Nov 3;167(4):1041-1051.e11
pubmed: 27881302